Christopher Chapman

Papers

Total Citations

H-Index

About

Christopher Chapman is a leading researcher in radiation oncology, with a primary focus on stereotactic body radiation therapy (SBRT) and respiratory motion management for lung cancer treatment. His most cited work, a 2018 study on the influence of respiratory motion management technique on radiation pneumonitis risk, demonstrates his commitment to improving clinical outcomes. In this pivotal paper, Chapman quantified the advantage of real-time tumor tracking (RTT) over the internal target volume (ITV) method, showing that RTT reduces radiation exposure to healthy lung tissue and lowers the risk of radiation pneumonitis. With 9 citations, this study has informed clinical practice and sparked further investigation into motion-adaptive radiotherapy. Chapman’s contributions bridge the gap between advanced technology and patient safety, offering tangible benefits for lung SBRT patients. His work is essential reading for researchers and clinicians seeking to optimize treatment precision and minimize toxicity. Through his research, Chapman continues to advance the field of radiation oncology, making him a notable figure in the development of safer, more effective cancer therapies.